Suppr超能文献

相似文献

1
Influenza Virus.
Transfus Med Hemother. 2008;35(1):42-49. doi: 10.1159/000111480. Epub 2007 Dec 3.
2
Isolation of a recombinant influenza virus (Hsw 1 N2) from swine in Japan.
Arch Virol. 1980;66(3):271-4. doi: 10.1007/BF01314741.
4
Influenza virus replication in macrophages: balancing protection and pathogenesis.
J Gen Virol. 2017 Oct;98(10):2401-2412. doi: 10.1099/jgv.0.000922. Epub 2017 Sep 8.
5
Avian influenza virus: the threat of a pandemic.
Chang Gung Med J. 2006 Mar-Apr;29(2):130-4.
6
An overview of influenza A virus receptors.
Crit Rev Microbiol. 2011 May;37(2):157-65. doi: 10.3109/1040841X.2010.536523. Epub 2011 Mar 26.
7
Enzymological characteristics of avian influenza A virus neuraminidase.
Microbiol Immunol. 1987;31(11):1131-5. doi: 10.1111/j.1348-0421.1987.tb01347.x.
9
[Pneumonia associated with influenza virus infection].
Nihon Rinsho. 2006 Oct;64(10):1906-15.
10
[Discovery of men infected by avian influenza A (H9N2) virus].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1999 Jun 30;13(2):105-8.

引用本文的文献

1
Polyphenols as Antiviral Agents: Their Potential Against a Range of Virus Types.
Nutrients. 2025 Jul 16;17(14):2325. doi: 10.3390/nu17142325.
2
Silver Nanoparticle-Mediated Antiviral Efficacy against Enveloped Viruses: A Comprehensive Review.
Glob Chall. 2025 Mar 28;9(5):2400380. doi: 10.1002/gch2.202400380. eCollection 2025 May.
3
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
4
An alternative method for monitoring and interpreting influenza A in communities using wastewater surveillance.
Front Public Health. 2023 Jul 27;11:1141136. doi: 10.3389/fpubh.2023.1141136. eCollection 2023.
7
Airway tight junctions as targets of viral infections.
Tissue Barriers. 2021 Apr 3;9(2):1883965. doi: 10.1080/21688370.2021.1883965. Epub 2021 Feb 26.

本文引用的文献

1
H5N1 influenza virus and the safety of plasma products.
Transfusion. 2007 Mar;47(3):452-9. doi: 10.1111/j.1537-2995.2007.01135.x.
2
Seasonal and pandemic influenza preparedness: science and countermeasures.
J Infect Dis. 2006 Nov 1;194 Suppl 2:S73-6. doi: 10.1086/507550.
3
Antiviral management of seasonal and pandemic influenza.
J Infect Dis. 2006 Nov 1;194 Suppl 2:S119-26. doi: 10.1086/507552.
4
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.
Clin Infect Dis. 2006 Dec 15;43(12):1555-61. doi: 10.1086/508777. Epub 2006 Nov 8.
5
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
Nat Med. 2006 Oct;12(10):1203-7. doi: 10.1038/nm1477. Epub 2006 Sep 10.
6
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.
J Infect Dis. 2006 Jun 15;193(12):1626-9. doi: 10.1086/504723. Epub 2006 May 9.
7
[Molecular characterization of human influenza viruses--a look back on the last 10 years].
Berl Munch Tierarztl Wochenschr. 2006 Mar-Apr;119(3-4):167-78.
9
Antiviral resistance in influenza viruses--implications for management and pandemic response.
N Engl J Med. 2006 Feb 23;354(8):785-8. doi: 10.1056/NEJMp068030.
10
The first confirmed human case of avian influenza A (H5N1) in Mainland China.
Lancet. 2006 Jan 7;367(9504):84. doi: 10.1016/S0140-6736(05)67894-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验